Skip to main content

Aims and Scope

The Journal of Cannabis Research is a fully open access, peer-reviewed journal that welcomes submissions covering all topics pertaining to cannabis. Our goal is to provide an outlet for experts across disciplines and foster innovation and collaboration, driving public discourse and around this timely issue and furthering this exciting area of research. 

Read the aims and scope

Journal of Cannabis Research accepted to Scopus

Scopus logoWe are delighted to announce that, from 2023, the Journal of Cannabis Research will be listed in the Scopus citation database. This will extend the visibility of our authors' research and build on our ability to provide an impactful, broad-scope forum for cannabis research.
Visit our Author Guidelines to submit to us today!

Editor's Article Highlights from 2022

Patient caught breastfeeding and instructed to stop: an empirical ethics study on marijuana and lactation
Marielle S. Gross, Margot Le Neveu, Kara A. Milliken & Mary Catherine Beach
Licensed and unlicensed cannabis outlets in Los Angeles County: the potential implications of location for social equity
Caislin L. Firth, Kristin M. Warren, Lilian Perez, Beau Kilmer, Regina A. Shih, Joan S. Tucker, Elizabeth J. D’Amico & Eric R. Pedersen
THC labeling on cannabis products: an experimental study of approaches for labeling THC servings on cannabis edibles
Samantha Goodman & David Hammond
Characteristics that influence purchase choice for cannabis products: a systematic review
Jennifer Donnan, Omar Shogan, Lisa Bishop, Michelle Swab & Maisam Najafizada
Delta-8-THC: Delta-9-THC’s nicer younger sibling?
Jessica S. Kruger & Daniel J. Kruger

In Memoriam: Raphael Mechoulam

New Content ItemIt is with great sadness that the Journal of Cannabis Research report the death of world-renowned cannabis researcher and our valued editorial board member, Raphael Mechoulam, PhD, on March 9, 2023.

Read a tribute from our Editor-in-Chief

Read More

Truly multidisciplinary

Our journal welcomes all aspects of cannabis research, divided into the following sections:

  • Agriculture and plant biology
  • Commerce, business, and environment
  • Endocannabinoid system
  • Cannabis and cannabinoids biochemistry and genetics
  • Cannabis and cannabinoids preclinical pharmacology
  • Cannabis and cannabinoids clinical pharmacology
  • Epidemiology and public health
  • Cannabis-related disorders
  • Medical cannabis
  • History, regulation, and public policy
Read about our sections

Thematic Series: The Two Sides of Hemp

Section Editor for Agriculture and Plant Biology, Dr Nirit Bernstein, is pleased to launch a new thematic series titled, "The Two Sides of Hemp: Medical and Industrial".

The collection aims to address hemp plant science; chemistry and cultivation; ethnobotany and regulations; medical and industrial uses of hemp and hemp products (such as cannabidiol); and differences between hemp and psychoactive cannabis.

Read More

About the Institute

Institute of Cannabis Research

The Institute of Cannabis Research was established in June 2016 through an innovative partnership between Colorado State University Pueblo, the state of Colorado, and Pueblo County.
The ICR is the first US multi-disciplinary cannabis research center at a regional, comprehensive institution. The primary function of the Institute is the generation of knowledge that contributes to science, medicine, and society through investigation of the benefits and risks associated with cannabis. Research findings are used to translate discoveries into innovative applications that improve lives. 

Journal of Cannabis Research is published in partnership with Colorado State University - Pueblo's Institute of Cannabis Research.

Visit the website

About the Editor-in-Chief

David GorelickDavid A. Gorelick, MD, PhD, DLFAPA, is Professor of Psychiatry (part-time) at the University of Maryland School of Medicine, having retired in October 2013 from the Intramural Research Program of the National Institute on Drug Abuse (NIDA), US National Institutes of Health (NIH) in Baltimore, Maryland.  

Dr Gorelick's research interests are the clinical pharmacology of substance use, substance withdrawal, and biological treatments of substance use disorders. His recent work focuses on cannabis (including its potential therapeutic uses), cocaine, and individuals with co-morbid psychiatric disorders.

Read more

New Content ItemThe Editor-in-Chief is a member of the International Society of Addiction Journal Editors

Affiliated with

Annual Journal Metrics

  • Speed
    95 days to first decision for all manuscripts (Median)
    134 days to first decision for reviewed manuscripts only (Median)

    672,036 Downloads (2022)
    1,222 Altmetric mentions (2021)